Cited by 3,381

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Molecular chaperones in protein folding and proteostasis

Hartl, F. Ulrich, Bracher, Andreas, Hayer-Hartl, Manajit·2011·Nature

Abstract

Most proteins must fold into defined three-dimensional structures to gain functional activity. But in the cellular environment, newly synthesized proteins are at great risk of aberrant folding and aggregation, potentially forming toxic species. To avoid these dangers, cells invest in a complex network of molecular chaperones, which use ingenious mechanisms to prevent aggregation and promote efficient folding. Because protein molecules are highly dynamic, constant chaperone surveillance is required to ensure protein homeostasis (proteostasis). Recent advances suggest that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease. Interventions in these and numerous other pathological states may spring from a detailed understanding of the pathways underlying proteome maintenance.

Overview

Integrity signals

Registry

Crossref · 10.1038/nature10317

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proteostasis involves mechanisms for the stabilization of correctly folded proteins, most prominently the heat-shock family of proteins, and mechanisms for the degradation of proteins by the proteasome or the lysosome.

    “Proteostasis involves mechanisms for the stabilization of correctly folded proteins, most prominently the heat-shock family of proteins, and mechanisms for the degradation of proteins by the proteasome or the lysosome (Hartl et al., 2011; Koga et al., 2011; Mizushima et al., 2008).”

    From The Hallmarks of Aging (2013) · cites this paper as Hartl et al., 2011

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 86

  1. Dobson, C. M., Sali, A. & Karplus, M. Protein folding — a perspective from theory and experiment. Angew. Chem. Int. Edn Engl. 37, 868–893 (1998). · DOI
  2. Bartlett, A. I. & Radford, S. E. An expanding arsenal of experimental methods yields an explosion of insights into protein folding mechanisms. Nature Struct. Mol. Biol. 16, 582–588 (2009). · DOI
  3. Dunker, A. K., Silman, I., Uversky, V. N. & Sussman, J. L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 18, 756–764 (2008). · DOI · Paper page
  4. Morimoto, R. I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22, 1427–1438 (2008). · DOI · Paper page
  5. Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. Adapting proteostasis for disease intervention. Science 319, 916–919 (2008). · DOI · Paper page
  6. Hartl, F. U. Molecular chaperones in cellular protein folding. Nature 381, 571–580 (1996). · DOI
  7. Kubelka, J., Hofrichter, J. & Eaton, W. A. The protein folding 'speed limit'. Curr. Opin. Struct. Biol. 14, 76–88 (2004). · DOI
  8. Herbst, R., Schafer, U. & Seckler, R. Equilibrium intermediates in the reversible unfolding of firefly (Photinus pyralis) luciferase. J. Biol. Chem. 272, 7099–7105 (1997). · DOI
  9. Ellis, R. J. & Minton, A. P. Protein aggregation in crowded environments. Biol. Chem. 387, 485–497 (2006). · DOI
  10. Tokuriki, N. & Tawfik, D. S. Chaperonin overexpression promotes genetic variation and enzyme evolution. Nature 459, 668–671 (2009). · DOI
  11. Skach, W. R. Cellular mechanisms of membrane protein folding. Nature Struct. Mol. Biol. 16, 606–612 (2009). · DOI
  12. Kerner, M. J. et al. Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli . Cell 122, 209–220 (2005). · DOI
  13. Eichner, T., Kalverda, A. P., Thompson, G. S., Homans, S. W. & Radford, S. E. Conformational conversion during amyloid formation at atomic resolution. Mol. Cell 41, 161–172 (2011). This exciting paper describes, at atomic resolution, the structural features of a non-native folding intermediate that are critical for amyloidogenic aggregation. · DOI
  14. Chiti, F. & Dobson, C. M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333–366 (2006). · DOI
  15. Bolognesi, B. et al. ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5, 735–740 (2010) This paper provides evidence that the exposure of hydrophobic surfaces by oligomeric aggregation intermediates correlates with their toxicity. · DOI
  16. Hartl, F. U. & Hayer-Hartl, M. Converging concepts of protein folding in vitro and in vivo . Nature Struct. Mol. Biol. 16, 574–581 (2009). · DOI
  17. Langer, T. et al. Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature 356, 683–689 (1992). · DOI
  18. Frydman, J., Nimmesgern, E., Ohtsuka, K. & Hartl, F. U. Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones. Nature 370, 111–117 (1994). · DOI
  19. Ellis, R. J. Molecular chaperones: assisting assembly in addition to folding. Trends Biochem. Sci. 31, 395–401 (2006). · DOI
  20. Liu, C. et al. Coupled chaperone action in folding and assembly of hexadecameric Rubisco. Nature 463, 197–202 (2010). · DOI
  21. Mayer, M. P. Gymnastics of molecular chaperones. Mol. Cell 39, 321–331 (2010). · DOI
  22. Kampinga, H. H. & Craig, E. A. The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nature Rev. Mol. Cell Biol. 11, 579–592 (2010). · DOI
  23. Arndt, V. et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr. Biol. 20, 143–148 (2010). · DOI
  24. Rüdiger, S., Buchberger, A. & Bukau, B. Interaction of Hsp70 chaperones with substrates. Nature Struct. Biol. 4, 342–349 (1997). A key paper in understanding how chaperones recognize their substrates. · DOI
  25. Rousseau, F., Serrano, L. & Schymkowitz, J. W. H. How evolutionary pressure against protein aggregation shaped chaperone specificity. J. Mol. Biol. 355, 1037–1047 (2006). · DOI
  26. Sharma, S. K., De los Rios, P., Christen, P., Lustig, A. & Goloubinoff, P. The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase. Nature Chem. Biol. 6, 914–920 (2010). · DOI
  27. Frydman, J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu. Rev. Biochem. 70, 603–647 (2001). · DOI
  28. Horwich, A. L. & Fenton, W. A. Chaperonin-mediated protein folding: using a central cavity to kinetically assist polypeptide chain folding. Q. Rev. Biophys. 42, 83–116 (2009). · DOI
  29. Fujiwara, K., Ishihama, Y., Nakahigashi, K., Soga, T. & Taguchi, H. A systematic survey of in vivo obligate chaperonin-dependent substrates. EMBO J. 29, 1552–1564 (2010). · DOI
  30. Raineri, E., Ribeca, P., Serrano, L. & Maier, T. A more precise characterization of chaperonin substrates. Bioinformatics 26, 1685–1689 (2010). · DOI
  31. Tartaglia, G. G., Dobson, C. M., Hartl, F. U. & Vendruscolo, M. Physicochemical determinants of chaperone requirements. J. Mol. Biol. 400, 579–588 (2010). · DOI
  32. Xu, Z. H., Horwich, A. L. & Sigler, P. B. The crystal structure of the asymmetric GroEL−GroES−(ADP)7 chaperonin complex. Nature 388, 741–749 (1997). · DOI
  33. Brinker, A. et al. Dual function of protein confinement in chaperonin-assisted protein folding. Cell 107, 223–233 (2001). · DOI
  34. Tang, Y. C. et al. Structural features of the GroEL−GroES nano-cage required for rapid folding of encapsulated protein. Cell 125, 903–914 (2006). · DOI
  35. Chakraborty, K. et al. Chaperonin-catalyzed rescue of kinetically trapped states in protein folding. Cell 142, 112–122 (2010). · DOI
  36. Thirumalai, D. & Lorimer, G. H. Chaperonin-mediated protein folding. Annu. Rev. Biophys. Biomol. Struct. 30, 245–269 (2001). · DOI
  37. Lin, Z., Madan, D. & Rye, H. S. GroEL stimulates protein folding through forced unfolding. Nature Struct. Mol. Biol. 15, 303–311 (2008). · DOI
  38. Sharma, S. et al. Monitoring protein conformation along the pathway of chaperonin-assisted folding. Cell 133, 142–153 (2008). · DOI
  39. Munoz, I. G. et al. Crystal structure of the open conformation of the mammalian chaperonin CCT in complex with tubulin. Nature Struct. Mol. Biol. 18, 14–19 (2011). · DOI
  40. Douglas, N. R. et al. Dual action of ATP hydrolysis couples lid closure to substrate release into the Group II chaperonin chamber. Cell 144, 240–252 (2011). · DOI
  41. Reissmann, S., Parnot, C., Booth, C. R., Chiu, W. & Frydman, J. Essential function of the built-in lid in the allosteric regulation of eukaryotic and archaeal chaperonins. Nature Struct. Mol. Biol. 14, 432–440 (2007). · DOI
  42. Kitamura, A. et al. Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state. Nature Cell Biol. 8, 1163–1170 (2006). · DOI
  43. Behrends, C. et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol. Cell 23, 887–897 (2006). · DOI
  44. Tam, S., Geller, R., Spiess, C. & Frydman, J. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nature Cell Biol. 8, 1155–1162 (2006). · DOI
  45. Wandinger, S. K., Richter, K. & Buchner, J. The Hsp90 chaperone machinery. J. Biol. Chem. 283, 18473–18477 (2008). · DOI
  46. Shiau, A. K., Harris, S. F., Southworth, D. R. & Agard, D. A. Structural analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 127, 329–340 (2006). · DOI · Paper page
  47. Neckers, L. Heat shock protein 90: the cancer chaperone. J. Biosci. 32, 517–530 (2007). · DOI
  48. Geller, R., Vignuzzi, M., Andino, R. & Frydman, J. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 21, 195–205 (2007). This seminal study describes the requirement of HSP90 in viral assembly, outlining a strategy for antiviral treatment based on HSP90 inhibition. · DOI
  49. Eichmann, C., Preissler, S., Riek, R. & Deuerling, E. Cotranslational structure acquisition of nascent polypeptides monitored by NMR spectroscopy. Proc. Natl Acad. Sci. USA 107, 9111–9116 (2010). · DOI
  50. Cabrita, L. D., Hsu, S. T., Launay, H., Dobson, C. M. & Christodoulou, J. Probing ribosome-nascent chain complexes produced in vivo by NMR spectroscopy. Proc. Natl Acad. Sci. USA 106, 22239–22244 (2009). · DOI
  51. Lu, J. L. & Deutsch, C. Folding zones inside the ribosomal exit tunnel. Nature Struct. Mol. Biol. 12, 1123–1129 (2005). · DOI
  52. Woolhead, C. A., McCormick, P. J. & Johnson, A. E. Nascent membrane and secretory proteins differ in FRET-detected folding far inside the ribosome and in their exposure to ribosomal proteins. Cell 116, 725–736 (2004). · DOI
  53. O'Brien, E. P., Hsu, S.-T. D., Christodoulou, J., Vendruscolo, M. & Dobson, C. M. Transient tertiary structure formation within the ribosome exit port. J. Am. Chem. Soc. 132, 16928–16937 (2010). · DOI
  54. Elcock, A. H. Molecular simulations of cotranslational protein folding: fragment stabilities, folding cooperativity, and trapping in the ribosome. PLoS Comput Biol. 2, e98 (2006). · DOI
  55. Ferbitz, L. et al. Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins. Nature 431, 590–596 (2004). · DOI
  56. Kaiser, C. M. et al. Real-time observation of trigger factor function on translating ribosomes. Nature 444, 455–460 (2006). · DOI
  57. Netzer, W. J. & Hartl, F. U. Recombination of protein domains facilitated by co-translational folding in eukaryotes. Nature 388, 343–349 (1997). · DOI
  58. Frydman, J., Erdjument-Bromage, H., Tempst, P. & Hartl, F. U. Co-translational domain folding as the structural basis for the rapid de novo folding of firefly luciferase. Nature Struct. Biol. 6, 697–705 (1999). · DOI
  59. Agashe, V. R. et al. Function of trigger factor and DnaK in multidomain protein folding: increase in yield at the expense of folding speed. Cell 117, 199–209 (2004). · DOI
  60. Cuellar, J. et al. The structure of CCT–Hsc70NBD suggests a mechanism for Hsp70 delivery of substrates to the chaperonin. Nature Struct. Mol. Biol. 15, 858–864 (2008). · DOI
  61. Zhang, G. & Ignatova, Z. Generic algorithm to predict the speed of translational elongation: implications for protein biogenesis. PLoS ONE 4, e5036 (2009). · DOI
  62. Vabulas, R. M. & Hartl, F. U. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310, 1960–1963 (2005). · DOI
  63. Buchberger, A., Bukau, B. & Sommer, T. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell 40, 238–252 (2010). · DOI · Paper page
  64. Vavouri, T., Semple, J. I., Garcia-Verdugo, R. & Lehner, B. Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 138, 198–208 (2009). · DOI
  65. Arndt, V., Rogon, C. & Hohfeld, J. To be, or not to be — molecular chaperones in protein degradation. Cell. Mol. Life Sci. 64, 2525–2541 (2007). · DOI
  66. Iwata, A., Riley, B. E., Johnston, J. A. & Kopito, R. R. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J. Biol. Chem. 280, 40282–40292 (2005). · DOI · Paper page
  67. Kopito, R. R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524–530 (2000). · DOI
  68. Kern, A., Ackermann, B., Clement, A. M., Duerk, H. & Behl, C. HSF1-controlled and age-associated chaperone capacity in neurons and muscle cells of C. elegans . PLoS ONE 5, e8568 (2010). · DOI
  69. Demontis, F. & Perrimon, N. FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging. Cell 143, 813–825 (2010). · DOI · Paper page
  70. Morley, J. F. & Morimoto, R. I. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Mol. Biol. Cell 15, 657–664 (2004). This pioneering study provides important insight into the relationship between molecular chaperone functions and longevity. · DOI
  71. Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W. & Dillin, A. Opposing activities protect against age-onset proteotoxicity. Science 313, 1604–1610 (2006). An exciting study demonstrating that active disaggregation and the forced formation of large inclusions prevent the accumulation of toxic aggregate species in C. elegans. · DOI · Paper page
  72. Ben-Zvi, A., Miller, E. A. & Morimoto, R. I. Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl Acad. Sci. USA 106, 14914–14919 (2009). · DOI · Paper page
  73. Cohen, E. et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 139, 1157–1169 (2009). · DOI · Paper page
  74. Olzscha, H. et al. Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67–78 (2011). This paper demonstrates the existence of a metastable sub-proteome that is at risk of co-aggregating with amyloid-forming disease proteins. · DOI
  75. Xu, J. et al. Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nature Chem. Biol. 7, 285–295 (2011). This interesting study expands the range of diseases promoted by proteostasis deficiency to cancer. · DOI · Paper page
  76. Bence, N. F., Sampat, R. M. & Kopito, R. R. Impairment of the ubiquitin−proteasome system by protein aggregation. Science 292, 1552–1555 (2001). This key paper demonstrates that protein aggregation can interfere with protein degradation. · DOI
  77. Schaffar, G. et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15, 95–105 (2004). · DOI
  78. Lotz, G. P. et al. Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle. J. Biol. Chem. 285, 38183–38193 (2010). · DOI
  79. Mu, T. W. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769–781 (2008). · DOI
  80. Lee, B.-H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179–184 (2010). This study describes the first drug-like molecule that can activate proteasome function, thus providing a means to enhance the clearance of aberrantly folded proteins. · DOI · Paper page
  81. Jahn, T. R. & Radford, S. E. The Yin and Yang of protein folding. FEBS J. 272, 5962–5970 (2005). · DOI
  82. Vabulas, R. M., Raychaudhuri, S., Hayer-Hartl, M. & Hartl, F. U. Protein folding in the cytoplasm and the heat shock response. Cold Spring Harb. Perspect. Biol. 2, a004390 (2010). · DOI
  83. Ryan, M. T. & Hoogenraad, N. J. Mitochondrial-nuclear communications. Annu. Rev. Biochem. 76, 701–722 (2007). · DOI · Paper page
  84. Haynes, C. M. & Ron, D. The mitochondrial UPR — protecting organelle protein homeostasis. J. Cell Sci. 123, 3849–3855 (2010). · DOI
  85. Kenyon, C. J. The genetics of ageing. Nature 464, 504–512 (2010). · DOI · Paper page
  86. Westerheide, S. D., Anckar, J., Stevens, S. M., Jr, Sistonen, L. & Morimoto, R. I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323, 1063–1066 (2009). · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Hartl, F. U., Bracher, A., & Hayer-Hartl, M.
Venue
Nature
Published
2011-07
Volume
475
Issue
7356
Pages
324-332
ISSN
  • 0028-0836
  • 1476-4687
Cited by
3,381
References
14
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review